These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 7832221

  • 1. Lens changes after proton beam irradiation for uveal melanoma.
    Gragoudas ES, Egan KM, Walsh SM, Regan S, Munzenrider JE, Taratuta V.
    Am J Ophthalmol; 1995 Feb; 119(2):157-64. PubMed ID: 7832221
    [Abstract] [Full Text] [Related]

  • 2. The Lens Opacities Classification System III Grading in Irradiated Uveal Melanomas to Characterize Proton Therapy-Induced Cataracts.
    Mathis T, Rosier L, Meniai F, Baillif S, Maschi C, Herault J, Caujolle JP, Kodjikian L, Salleron J, Thariat J.
    Am J Ophthalmol; 2019 May; 201():63-71. PubMed ID: 30721686
    [Abstract] [Full Text] [Related]

  • 3. Cataract development in patients treated with proton beam therapy for uveal melanoma.
    Seibel I, Cordini D, Hager A, Riechardt AI, Rehak M, Böker A, Böhmer D, Heufelder J, Joussen AM.
    Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1625-1630. PubMed ID: 27116211
    [Abstract] [Full Text] [Related]

  • 4. Anterior segment complications after helium ion radiation therapy for uveal melanoma. Radiation cataract.
    Meecham WJ, Char DH, Kroll S, Castro JR, Blakely EA.
    Arch Ophthalmol; 1994 Feb; 112(2):197-203. PubMed ID: 8311772
    [Abstract] [Full Text] [Related]

  • 5. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
    Pagliara MM, Tagliaferri L, Azario L, Lenkowicz J, Lanza A, Autorino R, Caputo CG, Gambacorta MA, Valentini V, Blasi MA.
    Brachytherapy; 2018 Feb; 17(2):432-438. PubMed ID: 29275868
    [Abstract] [Full Text] [Related]

  • 6. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
    Puusaari I, Heikkonen J, Kivelä T.
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
    Mishra KK, Daftari IK, Weinberg V, Cole T, Quivey JM, Castro JR, Phillips TL, Char DH.
    Int J Radiat Oncol Biol Phys; 2013 Oct 01; 87(2):330-6. PubMed ID: 23886415
    [Abstract] [Full Text] [Related]

  • 8. Helium-ion-induced human cataractogenesis.
    Blakely EA, Daftari IK, Meecham WJ, Alonso LC, Collier JM, Kroll SM, Gillette EL, Lee AC, Lett JT, Cox AB, Castro JR, Char DH.
    Adv Space Res; 1994 Oct 01; 14(10):501-5. PubMed ID: 11539986
    [Abstract] [Full Text] [Related]

  • 9. Cataract Avoidance With Proton Therapy in Ocular Melanomas.
    Thariat J, Jacob S, Caujolle JP, Maschi C, Baillif S, Angellier G, Mathis T, Rosier L, Carnicer A, Hérault J, Salleron J.
    Invest Ophthalmol Vis Sci; 2017 Oct 01; 58(12):5378-5386. PubMed ID: 29049739
    [Abstract] [Full Text] [Related]

  • 10. Lenticular opacities in individuals exposed to ionizing radiation in infancy.
    Hall P, Granath F, Lundell M, Olsson K, Holm LE.
    Radiat Res; 1999 Aug 01; 152(2):190-5. PubMed ID: 10409329
    [Abstract] [Full Text] [Related]

  • 11. Cataractogenesis after Cobalt-60 eye plaque radiotherapy.
    Kleineidam M, Augsburger JJ, Hernandez C, Glennon P, Brady LW.
    Int J Radiat Oncol Biol Phys; 1993 Jul 15; 26(4):625-30. PubMed ID: 8330992
    [Abstract] [Full Text] [Related]

  • 12. Plaque radiation therapy for malignant melanoma of the iris and ciliary body.
    Finger PT.
    Am J Ophthalmol; 2001 Sep 15; 132(3):328-35. PubMed ID: 11530044
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for cataract after palladium-103 ophthalmic plaque radiation therapy.
    Finger PT, Chin KJ, Yu GP, Patel NS, Palladium-103 for Choroidal Melanoma Study Group.
    Int J Radiat Oncol Biol Phys; 2011 Jul 01; 80(3):800-6. PubMed ID: 20615627
    [Abstract] [Full Text] [Related]

  • 14. Ocular complications after iodine brachytherapy for large uveal melanomas.
    Puusaari I, Heikkonen J, Kivelä T.
    Ophthalmology; 2004 Sep 01; 111(9):1768-77. PubMed ID: 15350335
    [Abstract] [Full Text] [Related]

  • 15. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
    Seibel I, Cordini D, Hager A, Tillner J, Riechardt AI, Heufelder J, Davids AM, Rehak M, Joussen AM.
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep 01; 254(9):1787-92. PubMed ID: 27376824
    [Abstract] [Full Text] [Related]

  • 16. Radiation dose to the lens and cataract formation.
    Henk JM, Whitelocke RA, Warrington AP, Bessell EM.
    Int J Radiat Oncol Biol Phys; 1993 Apr 02; 25(5):815-20. PubMed ID: 8478231
    [Abstract] [Full Text] [Related]

  • 17. Posterior uveal melanoma in young patients treated with proton beam therapy.
    Vavvas D, Kim I, Lane AM, Chaglassian A, Mukai S, Gragoudas E.
    Retina; 2010 Sep 02; 30(8):1267-71. PubMed ID: 20224468
    [Abstract] [Full Text] [Related]

  • 18. Intraocular inflammation after proton beam irradiation for uveal melanoma.
    Lumbroso L, Desjardins L, Levy C, Plancher C, Frau E, D'Hermies F, Schlienger P, Mammar H, Delacroix S, Nauraye C, Ferrand R, Desblancs C, Mazal A, Asselain B.
    Br J Ophthalmol; 2001 Nov 02; 85(11):1305-8. PubMed ID: 11673294
    [Abstract] [Full Text] [Related]

  • 19. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma.
    Summanen P, Immonen I, Kivelä T, Tommila P, Heikkonen J, Tarkkanen A.
    Br J Ophthalmol; 1996 Aug 02; 80(8):732-9. PubMed ID: 8949719
    [Abstract] [Full Text] [Related]

  • 20. Eye Lens Opacities Among Physicians Occupationally Exposed to Ionizing Radiation.
    Auvinen A, Kivelä T, Heinävaara S, Mrena S.
    Ann Occup Hyg; 2015 Aug 02; 59(7):945-8. PubMed ID: 25868644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.